A phase I pharmacokinetic and pharmacodynamic study of TKI258, an oral, multitargeted receptor tyrosine kinase inhibitor in patients with advanced solid tumors (Q46669648)
Jump to navigation
Jump to search
scientific article published in April 2008
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A phase I pharmacokinetic and pharmacodynamic study of TKI258, an oral, multitargeted receptor tyrosine kinase inhibitor in patients with advanced solid tumors |
scientific article published in April 2008 |
Statements
1 reference
A phase I pharmacokinetic and pharmacodynamic study of TKI258, an oral, multitargeted receptor tyrosine kinase inhibitor in patients with advanced solid tumors (English)
1 reference
Debashis Sarker
1 reference
Rhoda Molife
1 reference
T R Jeffrey Evans
1 reference
Maryon Hardie
1 reference
Cheryl Marriott
1 reference
Priska Butzberger-Zimmerli
1 reference
Rosemary Morrison
1 reference
Judith A Fox
1 reference
Carla Heise
1 reference
Sharianne Louie
1 reference
Natasha Aziz
1 reference
Felix Garzon
1 reference
Glenn Michelson
1 reference
Ian R Judson
1 reference
Dalal Jadayel
1 reference
Edgar Braendle
1 reference
Johann S de Bono
1 reference
1 April 2008
1 reference
1 reference
14
1 reference
2075-2081
1 reference
7
1 reference
Identifiers
1 reference
1 reference